Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNatthaphat Siri‐angkulen_US
dc.contributor.authorBehzad Dadfaren_US
dc.contributor.authorRiya Jaleelen_US
dc.contributor.authorJazna Naushaden_US
dc.contributor.authorJaseela Parambathazhathen_US
dc.contributor.authorAngelia A. Doyeen_US
dc.contributor.authorLai Hua Xieen_US
dc.contributor.authorJudith K. Gwathmeyen_US
dc.description.abstractThe occurrence and prevalence of heart failure remain high in the United States as well as globally. One person dies every 30 seconds from heart disease. Recognizing the importance of heart failure, clinicians and scientists have sought better therapeutic strategies and even cures for end-stage heart failure. This exploration has resulted in many failed clinical trials testing novel classes of pharmaceutical drugs and even gene therapy. As a result, along the way, there have been paradigm shifts toward and away from differing therapeutic approaches. The continued prevalence of death from heart failure, however, clearly demonstrates that the heart is not simply a pump and instead forces us to consider the complexity of simplicity in the pathophysiology of heart failure and reinforces the need to discover new therapeutic approaches.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemical Engineeringen_US
dc.subjectComputer Scienceen_US
dc.titleCalcium and heart failure: How did we get here and where are we going?en_US
article.title.sourcetitleInternational Journal of Molecular Sciencesen_US
article.volume22en_US, Inc.en_US Cornell Medicine-Qataren_US Universityen_US University School of Medicineen_US New Jersey Medical Schoolen_US Mai Universityen_US of Medicine MAZUMSen_US Dynamics Laboratoriesen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.